Gain Therapeutics Statistics
NASDAQ: GANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.62-0.05 (-2.99%)
Market open · Delayed 15 min · as of Oct 8, 1:39 PM ET
Gain Therapeutics by the numbers
Gain Therapeutics has a market capitalization of $70.7 million based on 43.64M shares outstanding. With trailing EPS of $-0.50, Gain Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 11.3% below its 50-day average and 18.4% below its 200-day average.
Average daily trading volume is 497.54K shares, or about $806,013 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
GANX valuation vs. peer median
| Metric | GANX | Peer median | Difference |
|---|---|---|---|
| Market cap | $70.70M | $71.68M | -1% |
| Avg. volume | 497.54K | 561.48K | -11% |
Peer median across 8 companies: ONCY, NTHI, VRCA, OSTX, MAIA, LFVN, TENX, HRTX.
Valuation
- Market cap
- $70.70M
- EPS (TTM)
- $-0.50
- Shares outstanding
- 43.64M
Price and trading
- Previous close
- 1.67
- Open
- 1.68
- Day range
- 1.61 – 1.68
- 52-week range
- 1.53 – 4.34
- 52-week change
- -17.33%
- Beta
- —
- Volume
- 176.67K
- Average volume
- 497.54K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2025
Additional statistics
- Market Cap
- 70.70M
- Forward Pe
- -2.36
- Eps
- -0.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 4.34
- Week52 Low
- 1.53
- Avg Volume
- 497.54K
- Shares Outstanding
- 43.64M
- Ma50
- 1.83
- Ma200
- 1.99
- Earnings Date
- Aug 6, 2025
- Pct From52w High
- -62.67%
- Pct From52w Low
- 5.88%